• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受深部脑刺激治疗的帕金森病相关遗传学。

Parkinson-related genetics in patients treated with deep brain stimulation.

机构信息

Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway.

出版信息

Acta Neurol Scand. 2011 Mar;123(3):201-6. doi: 10.1111/j.1600-0404.2010.01387.x.

DOI:10.1111/j.1600-0404.2010.01387.x
PMID:20545633
Abstract

OBJECTIVES

To analyze the frequency of mutations associated with Parkinson's disease (PD) in a general PD population compared to patients with PD selected for deep brain stimulation (DBS) and evaluate the outcome of surgery.

MATERIAL AND METHODS

A total of 630 consecutive patients with PD were genetically screened, and 60 had DBS surgery, 37 subthalamic nucleus (STN), 21 ventrointermediate nucleus of thalamus (VIM), and two globus pallidus internus (GPi).

RESULTS

Mutations in LRRK2, PRKN, and PINK1 were found: the first two of these being overrepresented in STN-operated patients, but none being found in VIM-operated patients. Clinical outcome of the surgery was similar in patients with mutations compared to those without.

CONCLUSIONS

In a consecutive PD population, patients treated with STN-DBS are overrepresented for PD-related mutations and they seem to benefit from DBS as well as patients without mutations.

摘要

目的

与因接受深部脑刺激 (DBS) 而选择的 PD 患者相比,分析一般 PD 人群中与帕金森病 (PD) 相关的突变频率,并评估手术结果。

材料和方法

对 630 例连续 PD 患者进行基因筛查,其中 60 例接受 DBS 手术,37 例为丘脑底核 (STN),21 例为丘脑腹中间核 (VIM),2 例为苍白球内 (GPi)。

结果

发现 LRRK2、PRKN 和 PINK1 突变:前两者在接受 STN 手术的患者中过度表达,但在接受 VIM 手术的患者中未发现。与无突变的患者相比,有突变的患者的手术临床效果相似。

结论

在连续的 PD 人群中,接受 STN-DBS 治疗的患者 PD 相关突变的发生率更高,他们似乎与无突变的患者一样受益于 DBS。

相似文献

1
Parkinson-related genetics in patients treated with deep brain stimulation.接受深部脑刺激治疗的帕金森病相关遗传学。
Acta Neurol Scand. 2011 Mar;123(3):201-6. doi: 10.1111/j.1600-0404.2010.01387.x.
2
Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.帕金森病中苍白球与丘脑底核深部脑刺激的比较
Arch Neurol. 2005 Apr;62(4):554-60. doi: 10.1001/archneur.62.4.554.
3
Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.对适合进行深部脑刺激的帕金森病患者进行丘脑底核谷氨酸脱羧酶基因转移。
Hum Gene Ther. 2001 Aug 10;12(12):1589-91.
4
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.多中心研究帕金森病丘脑底核和苍白球刺激的长期结果。
Mov Disord. 2010 Apr 15;25(5):578-86. doi: 10.1002/mds.22735.
5
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.帕金森病双侧脑深部电刺激:一项为期4年随访的多中心研究
Brain. 2005 Oct;128(Pt 10):2240-9. doi: 10.1093/brain/awh571. Epub 2005 Jun 23.
6
Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.在全身麻醉下借助术中微记录技术,为晚期帕金森病患者植入电极以对丘脑底核进行深部脑刺激。
Neurosurgery. 2006 Nov;59(5):E1138; discussion E1138. doi: 10.1227/01.NEU.0000245603.77075.55.
7
Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease.帕金森病患者接受分期双侧苍白球或丘脑底核深部脑刺激后的神经心理学表现。
J Int Neuropsychol Soc. 2007 Jan;13(1):68-79. doi: 10.1017/S1355617707070105.
8
Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.丘脑底核刺激不会导致帕金森病患者先前存在的幻觉恶化。
Stereotact Funct Neurosurg. 2009;87(1):45-9. doi: 10.1159/000195719. Epub 2009 Jan 28.
9
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients.丘脑底核刺激激活苍白球内侧部:来自帕金森病患者环磷酸鸟苷微透析的证据。
Ann Neurol. 2005 Mar;57(3):448-52. doi: 10.1002/ana.20402.
10
Micro lesion effect of the globus pallidus internus and outcome with deep brain stimulation in patients with Parkinson disease and dystonia.帕金森病和肌张力障碍患者苍白球内侧部的微损伤效应及深部脑刺激的结果
Mov Disord. 2009 Jul 30;24(10):1488-93. doi: 10.1002/mds.22641.

引用本文的文献

1
Surgicogenomics: The Role of Genetics in Deep Brain Stimulation in Parkinson's Disease Patients.手术基因组学:遗传学在帕金森病患者深部脑刺激中的作用
Brain Sci. 2024 Aug 9;14(8):800. doi: 10.3390/brainsci14080800.
2
Motor and Non-motor Outcomes of Deep Brain Stimulation across the Genetic Panorama of Parkinson's Disease: A Multi-Scale Meta-Analysis.帕金森病遗传全景中的深部脑刺激的运动和非运动结果:多尺度荟萃分析。
Mov Disord Clin Pract. 2024 May;11(5):465-477. doi: 10.1002/mdc3.13994. Epub 2024 Feb 6.
3
Deep brain stimulation of globus pallidus internus and subthalamic nucleus in Parkinson's disease: a multicenter, retrospective study of efficacy and safety.
深部脑刺激苍白球内侧和丘脑底核治疗帕金森病:多中心回顾性研究的疗效和安全性。
Neurol Sci. 2024 Jan;45(1):177-185. doi: 10.1007/s10072-023-06999-z. Epub 2023 Aug 9.
4
Deep brain stimulation in Early Onset Parkinson's disease.早期帕金森病的脑深部电刺激治疗
Front Neurol. 2022 Nov 17;13:1041449. doi: 10.3389/fneur.2022.1041449. eCollection 2022.
5
Precision Medicine in Parkinson's Disease: From Genetic Risk Signals to Personalized Therapy.帕金森病的精准医学:从遗传风险信号到个性化治疗
Brain Sci. 2022 Sep 28;12(10):1308. doi: 10.3390/brainsci12101308.
6
Deep brain stimulation for Parkinson's disease.脑深部电刺激术治疗帕金森病。
J Intern Med. 2022 Nov;292(5):764-778. doi: 10.1111/joim.13541. Epub 2022 Jul 13.
7
Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson's Disease.线粒体稳态的破坏:PINK1 在帕金森病中的作用。
Cells. 2021 Nov 4;10(11):3022. doi: 10.3390/cells10113022.
8
Diagnostic value of skin RT-QuIC in Parkinson's disease: a two-laboratory study.皮肤实时无细胞免疫检测法在帕金森病中的诊断价值:一项双实验室研究
NPJ Parkinsons Dis. 2021 Nov 15;7(1):99. doi: 10.1038/s41531-021-00242-2.
9
BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease.BDNF rs6265 基因型影响早期帕金森病药物治疗和丘脑底核深部脑刺激的疗效。
Neuromodulation. 2022 Aug;25(6):846-853. doi: 10.1111/ner.13504. Epub 2022 Jun 14.
10
Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort.挪威LRRK2突变携带者中的炎症性疾病。一个队列的15年随访
Front Neurosci. 2021 Jan 28;15:634666. doi: 10.3389/fnins.2021.634666. eCollection 2021.